Contact
searchSearch
HMP Global

Drug Recalls News

News
Cinacalcet Tablets Recalled Due to Failed Dissolution Specifications
10/29/2026
Rebecca Amrick
Cinacalcet tablets are under a voluntary Class II recall due to the product’s failure to meet dissolution specifications, affecting 49 488 bottles.
Cinacalcet tablets are under a voluntary Class II recall due to the product’s failure to meet dissolution specifications, affecting 49 488 bottles.
Cinacalcet tablets are under a...
10/29/2026
Pharmacy Learning Network
News
Heparin Sodium Injection Recalled Due to Lack of Sterility Assurance
10/29/2026
Rebecca Amrick
A voluntary Class II recall has been issued for heparin sodium injection due to the product’s lack of sterility assurance, affecting 251 000 vials.
A voluntary Class II recall has been issued for heparin sodium injection due to the product’s lack of sterility assurance, affecting 251 000 vials.
A voluntary Class II recall has...
10/29/2026
Pharmacy Learning Network
News
Abirtega Recalled Over Tablet Weight Uniformity
10/29/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for Abirtega (abiraterone acetate) after the tablets failed to meet weight uniformity specifications, affecting 2136 bottles.
The US Food and Drug Administration (FDA) has issued a Class II recall for Abirtega (abiraterone acetate) after the tablets failed to meet weight uniformity specifications, affecting 2136 bottles.
The US Food and Drug...
10/29/2026
Pharmacy Learning Network
News
Sermorelin Recalled Due to Lack of Process Control
10/22/2026
Rebecca Amrick
Sermorelin is under a voluntary Class II recall due to a lack of process control, affecting 7 vials.
Sermorelin is under a voluntary Class II recall due to a lack of process control, affecting 7 vials.
Sermorelin is under a voluntary...
10/22/2026
Pharmacy Learning Network
News
Tirzepatide/Niacinamide Recalled Due to Lack of Sterility Assurance
10/22/2026
Rebecca Amrick
A voluntary Class II recall has been issued for tirzepatide/niacinamide due to the product’s lack of sterility assurance, affecting 64 vials.
A voluntary Class II recall has been issued for tirzepatide/niacinamide due to the product’s lack of sterility assurance, affecting 64 vials.
A voluntary Class II recall has...
10/22/2026
Pharmacy Learning Network
News
Hydrocortisone Injection Recalled Due to the Failed Impurities Specifications
10/22/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for hydrocortisone sodium succinate injection due to failed impurities specifications, affecting 70 776 vials.
The US Food and Drug Administration (FDA) has issued a Class II recall for hydrocortisone sodium succinate injection due to failed impurities specifications, affecting 70 776 vials.
The US Food and Drug...
10/22/2026
Pharmacy Learning Network
News
BioSpectra Tris/Tromethamine Recalled Due to Failed Stability Specifications
10/15/2026
Rebecca Amrick
BioSpectra voluntarily recalled 200 kg of tris/tromethamine after the product failed to meet stability specifications, prompting a Class II classification by the FDA.
BioSpectra voluntarily recalled 200 kg of tris/tromethamine after the product failed to meet stability specifications, prompting a Class II classification by the FDA.
BioSpectra voluntarily recalled...
10/15/2026
Pharmacy Learning Network
News
Fosfomycin Tromethamine Recalled Due to Failed Impurities Specifications
10/15/2026
Rebecca Amrick
A voluntary Class II recall has been issued for fosfomycin tromethamine granules for oral solution due to the product’s failure to meet impurities specifications.
A voluntary Class II recall has been issued for fosfomycin tromethamine granules for oral solution due to the product’s failure to meet impurities specifications.
A voluntary Class II recall has...
10/15/2026
Pharmacy Learning Network
News
IMAAVY Injection Recalled Due to the Presence of Particulate Matter
10/15/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for IMAAVY (nipocalimab-aahu) injection due to the presence of particulate matter, affecting 49 vials.
The US Food and Drug Administration (FDA) has issued a Class II recall for IMAAVY (nipocalimab-aahu) injection due to the presence of particulate matter, affecting 49 vials.
The US Food and Drug...
10/15/2026
Pharmacy Learning Network
News
Estradiol Gel Recalled Due to Defective Container
10/08/2026
Rebecca Amrick
Estradiol gel is under a voluntary Class II recall after defects were discovered in the product’s container, affecting 2592 cartons.
Estradiol gel is under a voluntary Class II recall after defects were discovered in the product’s container, affecting 2592 cartons.
Estradiol gel is under a...
10/08/2026
Pharmacy Learning Network

Subscribe Today

Pharmacy Learning Network Newsletter

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use